0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Positive Allosteric Modulators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-9H10141
Home | Market Reports | Science| Biological Sciences
Global Positive Allosteric Modulators Market Research Report 2022
BUY CHAPTERS

Positive Allosteric Modulators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-9H10141
Report
November 2024
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Positive Allosteric Modulators - Market

The global market for Positive Allosteric Modulators was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Positive Allosteric Modulators was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Positive Allosteric Modulators was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Positive Allosteric Modulators was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Positive Allosteric Modulators include F. Hoffmann-La Roche, Pfizer, Taj Pharmaceuticals, Explicit Chemicals, Shaanxi Rebecca Bio-Tech, Zydus Cadila, ACADIA Pharmaceuticals, M Somerset Pharmaceuticals and Vertical Pharmaceuticals, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Positive Allosteric Modulators, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Positive Allosteric Modulators by region & country, by Type, and by Application.
The Positive Allosteric Modulators market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Positive Allosteric Modulators.
Market Segmentation

Scope of Positive Allosteric Modulators - Market Report

Report Metric Details
Report Name Positive Allosteric Modulators - Market
Segment by Type:
  • Benzodiazepines
  • Barbiturates
  • Amantadine
  • Other
Segment by Application
  • Parkinson’s Disease
  • Schizophrenia
  • Alzheimer’s Disease
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company F. Hoffmann-La Roche, Pfizer, Taj Pharmaceuticals, Explicit Chemicals, Shaanxi Rebecca Bio-Tech, Zydus Cadila, ACADIA Pharmaceuticals, M Somerset Pharmaceuticals, Vertical Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Positive Allosteric Modulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Positive Allosteric Modulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Positive Allosteric Modulators in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Positive Allosteric Modulators - Market report?

Ans: The main players in the Positive Allosteric Modulators - Market are F. Hoffmann-La Roche, Pfizer, Taj Pharmaceuticals, Explicit Chemicals, Shaanxi Rebecca Bio-Tech, Zydus Cadila, ACADIA Pharmaceuticals, M Somerset Pharmaceuticals, Vertical Pharmaceuticals

What are the Application segmentation covered in the Positive Allosteric Modulators - Market report?

Ans: The Applications covered in the Positive Allosteric Modulators - Market report are Parkinson’s Disease, Schizophrenia, Alzheimer’s Disease

What are the Type segmentation covered in the Positive Allosteric Modulators - Market report?

Ans: The Types covered in the Positive Allosteric Modulators - Market report are Benzodiazepines, Barbiturates, Amantadine, Other

1 Market Overview
1.1 Positive Allosteric Modulators Product Introduction
1.2 Global Positive Allosteric Modulators Market Size Forecast
1.2.1 Global Positive Allosteric Modulators Sales Value (2019-2030)
1.2.2 Global Positive Allosteric Modulators Sales Volume (2019-2030)
1.2.3 Global Positive Allosteric Modulators Sales Price (2019-2030)
1.3 Positive Allosteric Modulators Market Trends & Drivers
1.3.1 Positive Allosteric Modulators Industry Trends
1.3.2 Positive Allosteric Modulators Market Drivers & Opportunity
1.3.3 Positive Allosteric Modulators Market Challenges
1.3.4 Positive Allosteric Modulators Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Positive Allosteric Modulators Players Revenue Ranking (2023)
2.2 Global Positive Allosteric Modulators Revenue by Company (2019-2024)
2.3 Global Positive Allosteric Modulators Players Sales Volume Ranking (2023)
2.4 Global Positive Allosteric Modulators Sales Volume by Company Players (2019-2024)
2.5 Global Positive Allosteric Modulators Average Price by Company (2019-2024)
2.6 Key Manufacturers Positive Allosteric Modulators Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Positive Allosteric Modulators Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Positive Allosteric Modulators
2.9 Positive Allosteric Modulators Market Competitive Analysis
2.9.1 Positive Allosteric Modulators Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Positive Allosteric Modulators Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Positive Allosteric Modulators as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Benzodiazepines
3.1.2 Barbiturates
3.1.3 Amantadine
3.1.4 Other
3.2 Global Positive Allosteric Modulators Sales Value by Type
3.2.1 Global Positive Allosteric Modulators Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Positive Allosteric Modulators Sales Value, by Type (2019-2030)
3.2.3 Global Positive Allosteric Modulators Sales Value, by Type (%) (2019-2030)
3.3 Global Positive Allosteric Modulators Sales Volume by Type
3.3.1 Global Positive Allosteric Modulators Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Positive Allosteric Modulators Sales Volume, by Type (2019-2030)
3.3.3 Global Positive Allosteric Modulators Sales Volume, by Type (%) (2019-2030)
3.4 Global Positive Allosteric Modulators Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Parkinson’s Disease
4.1.2 Schizophrenia
4.1.3 Alzheimer’s Disease
4.2 Global Positive Allosteric Modulators Sales Value by Application
4.2.1 Global Positive Allosteric Modulators Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Positive Allosteric Modulators Sales Value, by Application (2019-2030)
4.2.3 Global Positive Allosteric Modulators Sales Value, by Application (%) (2019-2030)
4.3 Global Positive Allosteric Modulators Sales Volume by Application
4.3.1 Global Positive Allosteric Modulators Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Positive Allosteric Modulators Sales Volume, by Application (2019-2030)
4.3.3 Global Positive Allosteric Modulators Sales Volume, by Application (%) (2019-2030)
4.4 Global Positive Allosteric Modulators Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Positive Allosteric Modulators Sales Value by Region
5.1.1 Global Positive Allosteric Modulators Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Positive Allosteric Modulators Sales Value by Region (2019-2024)
5.1.3 Global Positive Allosteric Modulators Sales Value by Region (2025-2030)
5.1.4 Global Positive Allosteric Modulators Sales Value by Region (%), (2019-2030)
5.2 Global Positive Allosteric Modulators Sales Volume by Region
5.2.1 Global Positive Allosteric Modulators Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Positive Allosteric Modulators Sales Volume by Region (2019-2024)
5.2.3 Global Positive Allosteric Modulators Sales Volume by Region (2025-2030)
5.2.4 Global Positive Allosteric Modulators Sales Volume by Region (%), (2019-2030)
5.3 Global Positive Allosteric Modulators Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Positive Allosteric Modulators Sales Value, 2019-2030
5.4.2 North America Positive Allosteric Modulators Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Positive Allosteric Modulators Sales Value, 2019-2030
5.5.2 Europe Positive Allosteric Modulators Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Positive Allosteric Modulators Sales Value, 2019-2030
5.6.2 Asia Pacific Positive Allosteric Modulators Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Positive Allosteric Modulators Sales Value, 2019-2030
5.7.2 South America Positive Allosteric Modulators Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Positive Allosteric Modulators Sales Value, 2019-2030
5.8.2 Middle East & Africa Positive Allosteric Modulators Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Positive Allosteric Modulators Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Positive Allosteric Modulators Sales Value
6.2.1 Key Countries/Regions Positive Allosteric Modulators Sales Value, 2019-2030
6.2.2 Key Countries/Regions Positive Allosteric Modulators Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Positive Allosteric Modulators Sales Value, 2019-2030
6.3.2 United States Positive Allosteric Modulators Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Positive Allosteric Modulators Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Positive Allosteric Modulators Sales Value, 2019-2030
6.4.2 Europe Positive Allosteric Modulators Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Positive Allosteric Modulators Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Positive Allosteric Modulators Sales Value, 2019-2030
6.5.2 China Positive Allosteric Modulators Sales Value by Type (%), 2023 VS 2030
6.5.3 China Positive Allosteric Modulators Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Positive Allosteric Modulators Sales Value, 2019-2030
6.6.2 Japan Positive Allosteric Modulators Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Positive Allosteric Modulators Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Positive Allosteric Modulators Sales Value, 2019-2030
6.7.2 South Korea Positive Allosteric Modulators Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Positive Allosteric Modulators Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Positive Allosteric Modulators Sales Value, 2019-2030
6.8.2 Southeast Asia Positive Allosteric Modulators Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Positive Allosteric Modulators Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Positive Allosteric Modulators Sales Value, 2019-2030
6.9.2 India Positive Allosteric Modulators Sales Value by Type (%), 2023 VS 2030
6.9.3 India Positive Allosteric Modulators Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 F. Hoffmann-La Roche
7.1.1 F. Hoffmann-La Roche Company Information
7.1.2 F. Hoffmann-La Roche Introduction and Business Overview
7.1.3 F. Hoffmann-La Roche Positive Allosteric Modulators Sales, Revenue and Gross Margin (2019-2024)
7.1.4 F. Hoffmann-La Roche Positive Allosteric Modulators Product Offerings
7.1.5 F. Hoffmann-La Roche Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Information
7.2.2 Pfizer Introduction and Business Overview
7.2.3 Pfizer Positive Allosteric Modulators Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Pfizer Positive Allosteric Modulators Product Offerings
7.2.5 Pfizer Recent Development
7.3 Taj Pharmaceuticals
7.3.1 Taj Pharmaceuticals Company Information
7.3.2 Taj Pharmaceuticals Introduction and Business Overview
7.3.3 Taj Pharmaceuticals Positive Allosteric Modulators Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Taj Pharmaceuticals Positive Allosteric Modulators Product Offerings
7.3.5 Taj Pharmaceuticals Recent Development
7.4 Explicit Chemicals
7.4.1 Explicit Chemicals Company Information
7.4.2 Explicit Chemicals Introduction and Business Overview
7.4.3 Explicit Chemicals Positive Allosteric Modulators Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Explicit Chemicals Positive Allosteric Modulators Product Offerings
7.4.5 Explicit Chemicals Recent Development
7.5 Shaanxi Rebecca Bio-Tech
7.5.1 Shaanxi Rebecca Bio-Tech Company Information
7.5.2 Shaanxi Rebecca Bio-Tech Introduction and Business Overview
7.5.3 Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Product Offerings
7.5.5 Shaanxi Rebecca Bio-Tech Recent Development
7.6 Zydus Cadila
7.6.1 Zydus Cadila Company Information
7.6.2 Zydus Cadila Introduction and Business Overview
7.6.3 Zydus Cadila Positive Allosteric Modulators Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Zydus Cadila Positive Allosteric Modulators Product Offerings
7.6.5 Zydus Cadila Recent Development
7.7 ACADIA Pharmaceuticals
7.7.1 ACADIA Pharmaceuticals Company Information
7.7.2 ACADIA Pharmaceuticals Introduction and Business Overview
7.7.3 ACADIA Pharmaceuticals Positive Allosteric Modulators Sales, Revenue and Gross Margin (2019-2024)
7.7.4 ACADIA Pharmaceuticals Positive Allosteric Modulators Product Offerings
7.7.5 ACADIA Pharmaceuticals Recent Development
7.8 M Somerset Pharmaceuticals
7.8.1 M Somerset Pharmaceuticals Company Information
7.8.2 M Somerset Pharmaceuticals Introduction and Business Overview
7.8.3 M Somerset Pharmaceuticals Positive Allosteric Modulators Sales, Revenue and Gross Margin (2019-2024)
7.8.4 M Somerset Pharmaceuticals Positive Allosteric Modulators Product Offerings
7.8.5 M Somerset Pharmaceuticals Recent Development
7.9 Vertical Pharmaceuticals
7.9.1 Vertical Pharmaceuticals Company Information
7.9.2 Vertical Pharmaceuticals Introduction and Business Overview
7.9.3 Vertical Pharmaceuticals Positive Allosteric Modulators Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Vertical Pharmaceuticals Positive Allosteric Modulators Product Offerings
7.9.5 Vertical Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Positive Allosteric Modulators Industrial Chain
8.2 Positive Allosteric Modulators Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Positive Allosteric Modulators Sales Model
8.5.2 Sales Channel
8.5.3 Positive Allosteric Modulators Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Positive Allosteric Modulators Market Trends
    Table 2. Positive Allosteric Modulators Market Drivers & Opportunity
    Table 3. Positive Allosteric Modulators Market Challenges
    Table 4. Positive Allosteric Modulators Market Restraints
    Table 5. Global Positive Allosteric Modulators Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Positive Allosteric Modulators Revenue Market Share by Company (2019-2024)
    Table 7. Global Positive Allosteric Modulators Sales Volume by Company (2019-2024) & (Kiloton)
    Table 8. Global Positive Allosteric Modulators Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Positive Allosteric Modulators Price by Company (2019-2024) & (US$/Ton)
    Table 10. Key Manufacturers Positive Allosteric Modulators Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Positive Allosteric Modulators Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Positive Allosteric Modulators
    Table 13. Global Positive Allosteric Modulators Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Positive Allosteric Modulators as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Positive Allosteric Modulators Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Positive Allosteric Modulators Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Positive Allosteric Modulators Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Positive Allosteric Modulators Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Positive Allosteric Modulators Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Positive Allosteric Modulators Sales Volume by Type: 2019 VS 2023 VS 2030 (Kiloton)
    Table 22. Global Positive Allosteric Modulators Sales Volume by Type (2019-2024) & (Kiloton)
    Table 23. Global Positive Allosteric Modulators Sales Volume by Type (2025-2030) & (Kiloton)
    Table 24. Global Positive Allosteric Modulators Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Positive Allosteric Modulators Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Positive Allosteric Modulators Price by Type (2019-2024) & (US$/Ton)
    Table 27. Global Positive Allosteric Modulators Price by Type (2025-2030) & (US$/Ton)
    Table 28. Global Positive Allosteric Modulators Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Positive Allosteric Modulators Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Positive Allosteric Modulators Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Positive Allosteric Modulators Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Positive Allosteric Modulators Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Positive Allosteric Modulators Sales Volume by Application: 2019 VS 2023 VS 2030 (Kiloton)
    Table 34. Global Positive Allosteric Modulators Sales Volume by Application (2019-2024) & (Kiloton)
    Table 35. Global Positive Allosteric Modulators Sales Volume by Application (2025-2030) & (Kiloton)
    Table 36. Global Positive Allosteric Modulators Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Positive Allosteric Modulators Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Positive Allosteric Modulators Price by Application (2019-2024) & (US$/Ton)
    Table 39. Global Positive Allosteric Modulators Price by Application (2025-2030) & (US$/Ton)
    Table 40. Global Positive Allosteric Modulators Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Positive Allosteric Modulators Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Positive Allosteric Modulators Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Positive Allosteric Modulators Sales Value by Region (2019-2024) & (%)
    Table 44. Global Positive Allosteric Modulators Sales Value by Region (2025-2030) & (%)
    Table 45. Global Positive Allosteric Modulators Sales Volume by Region (Kiloton): 2019 VS 2023 VS 2030
    Table 46. Global Positive Allosteric Modulators Sales Volume by Region (2019-2024) & (Kiloton)
    Table 47. Global Positive Allosteric Modulators Sales Volume by Region (2025-2030) & (Kiloton)
    Table 48. Global Positive Allosteric Modulators Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Positive Allosteric Modulators Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Positive Allosteric Modulators Average Price by Region (2019-2024) & (US$/Ton)
    Table 51. Global Positive Allosteric Modulators Average Price by Region (2025-2030) & (US$/Ton)
    Table 52. Key Countries/Regions Positive Allosteric Modulators Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Positive Allosteric Modulators Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Positive Allosteric Modulators Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Positive Allosteric Modulators Sales Volume, (2019-2024) & (Kiloton)
    Table 56. Key Countries/Regions Positive Allosteric Modulators Sales Volume, (2025-2030) & (Kiloton)
    Table 57. F. Hoffmann-La Roche Company Information
    Table 58. F. Hoffmann-La Roche Introduction and Business Overview
    Table 59. F. Hoffmann-La Roche Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 60. F. Hoffmann-La Roche Positive Allosteric Modulators Product Offerings
    Table 61. F. Hoffmann-La Roche Recent Development
    Table 62. Pfizer Company Information
    Table 63. Pfizer Introduction and Business Overview
    Table 64. Pfizer Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 65. Pfizer Positive Allosteric Modulators Product Offerings
    Table 66. Pfizer Recent Development
    Table 67. Taj Pharmaceuticals Company Information
    Table 68. Taj Pharmaceuticals Introduction and Business Overview
    Table 69. Taj Pharmaceuticals Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 70. Taj Pharmaceuticals Positive Allosteric Modulators Product Offerings
    Table 71. Taj Pharmaceuticals Recent Development
    Table 72. Explicit Chemicals Company Information
    Table 73. Explicit Chemicals Introduction and Business Overview
    Table 74. Explicit Chemicals Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 75. Explicit Chemicals Positive Allosteric Modulators Product Offerings
    Table 76. Explicit Chemicals Recent Development
    Table 77. Shaanxi Rebecca Bio-Tech Company Information
    Table 78. Shaanxi Rebecca Bio-Tech Introduction and Business Overview
    Table 79. Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 80. Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Product Offerings
    Table 81. Shaanxi Rebecca Bio-Tech Recent Development
    Table 82. Zydus Cadila Company Information
    Table 83. Zydus Cadila Introduction and Business Overview
    Table 84. Zydus Cadila Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 85. Zydus Cadila Positive Allosteric Modulators Product Offerings
    Table 86. Zydus Cadila Recent Development
    Table 87. ACADIA Pharmaceuticals Company Information
    Table 88. ACADIA Pharmaceuticals Introduction and Business Overview
    Table 89. ACADIA Pharmaceuticals Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 90. ACADIA Pharmaceuticals Positive Allosteric Modulators Product Offerings
    Table 91. ACADIA Pharmaceuticals Recent Development
    Table 92. M Somerset Pharmaceuticals Company Information
    Table 93. M Somerset Pharmaceuticals Introduction and Business Overview
    Table 94. M Somerset Pharmaceuticals Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 95. M Somerset Pharmaceuticals Positive Allosteric Modulators Product Offerings
    Table 96. M Somerset Pharmaceuticals Recent Development
    Table 97. Vertical Pharmaceuticals Company Information
    Table 98. Vertical Pharmaceuticals Introduction and Business Overview
    Table 99. Vertical Pharmaceuticals Positive Allosteric Modulators Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 100. Vertical Pharmaceuticals Positive Allosteric Modulators Product Offerings
    Table 101. Vertical Pharmaceuticals Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Positive Allosteric Modulators Downstream Customers
    Table 105. Positive Allosteric Modulators Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Positive Allosteric Modulators Product Picture
    Figure 2. Global Positive Allosteric Modulators Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Positive Allosteric Modulators Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Positive Allosteric Modulators Sales Volume (2019-2030) & (Kiloton)
    Figure 5. Global Positive Allosteric Modulators Sales Price (2019-2030) & (US$/Ton)
    Figure 6. Positive Allosteric Modulators Report Years Considered
    Figure 7. Global Positive Allosteric Modulators Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Positive Allosteric Modulators Players Sales Volume Ranking (2023) & (Kiloton)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Positive Allosteric Modulators Revenue in 2023
    Figure 10. Positive Allosteric Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Benzodiazepines Picture
    Figure 12. Barbiturates Picture
    Figure 13. Amantadine Picture
    Figure 14. Other Picture
    Figure 15. Global Positive Allosteric Modulators Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Positive Allosteric Modulators Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Positive Allosteric Modulators Sales Volume by Type (2019 VS 2023 VS 2030) & (Kiloton)
    Figure 18. Global Positive Allosteric Modulators Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Positive Allosteric Modulators Price by Type (2019-2030) & (US$/Ton)
    Figure 20. Product Picture of Parkinson’s Disease
    Figure 21. Product Picture of Schizophrenia
    Figure 22. Product Picture of Alzheimer’s Disease
    Figure 23. Global Positive Allosteric Modulators Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Positive Allosteric Modulators Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Positive Allosteric Modulators Sales Volume by Application (2019 VS 2023 VS 2030) & (Kiloton)
    Figure 26. Global Positive Allosteric Modulators Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Positive Allosteric Modulators Price by Application (2019-2030) & (US$/Ton)
    Figure 28. North America Positive Allosteric Modulators Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Positive Allosteric Modulators Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Positive Allosteric Modulators Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Positive Allosteric Modulators Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Positive Allosteric Modulators Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Positive Allosteric Modulators Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Positive Allosteric Modulators Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Positive Allosteric Modulators Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Positive Allosteric Modulators Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Positive Allosteric Modulators Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Positive Allosteric Modulators Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Positive Allosteric Modulators Sales Volume (%), (2019-2030)
    Figure 40. United States Positive Allosteric Modulators Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Positive Allosteric Modulators Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Positive Allosteric Modulators Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Positive Allosteric Modulators Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Positive Allosteric Modulators Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Positive Allosteric Modulators Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Positive Allosteric Modulators Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Positive Allosteric Modulators Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Positive Allosteric Modulators Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Positive Allosteric Modulators Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Positive Allosteric Modulators Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Positive Allosteric Modulators Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Positive Allosteric Modulators Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Positive Allosteric Modulators Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Positive Allosteric Modulators Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Positive Allosteric Modulators Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Positive Allosteric Modulators Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Positive Allosteric Modulators Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Positive Allosteric Modulators Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Positive Allosteric Modulators Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Positive Allosteric Modulators Sales Value by Application (%), 2023 VS 2030
    Figure 61. Positive Allosteric Modulators Industrial Chain
    Figure 62. Positive Allosteric Modulators Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Biological Tissue Staining Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-15Z10629
Fri Nov 22 00:00:00 UTC 2024

Add to Cart

DNA Transfection Reagents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-7S9949
Fri Nov 22 00:00:00 UTC 2024

Add to Cart

Global Protein Wet Blotting System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-18U18627
Fri Nov 22 00:00:00 UTC 2024

Add to Cart

Positive Allosteric Modulators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-9H10141
Fri Nov 22 00:00:00 UTC 2024

Add to Cart